share_log

Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket

Benzinga Real-time News ·  Sep 22, 2022 18:36

Gainers

  • Spero Therapeutics, Inc. (NASDAQ:SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.
  • HeartBeam, Inc. (NASDAQ:BEAT) shares rose 27.8% to $2.02 in pre-market trading after dropping 16% on Wednesday. Heartbeam recently announced its patent for a 12-lead electrocardiogram patch monitor intended for detection of acute coronary syndrome and cardiac arrhythmia was issued by the USPTO.
  • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) rose 20.1% to $0.2590 in pre-market trading.
  • Taoping Inc. (NASDAQ:TAOP) rose 19.7% to $0.73 in pre-market trading. Taoping recently posted 1H revenue of $10.5 million.
  • Acorda Therapeutics, Inc. (NASDAQ:ACOR) rose 18.4% to $0.3672 in pre-market trading after declining around 7% on Wednesday.
  • Lytus Technologies Holdings PTV. Ltd. (NASDAQ:LYT) rose 15.8% to $1.90 in pre-market trading after dropping over 5% on Wednesday.
  • Organovo Holdings, Inc. (NASDAQ:ONVO) rose 15.3% to $2.45 in pre-market trading.
  • Ensysce Biosciences, Inc. (NASDAQ:ENSC) rose 12% to $0.2660 in pre-market trading after declining 5% on Wednesday.
  • Comera Life Sciences Holdings, Inc. (NASDAQ:CMRA) rose 11.2% to $1.98 in pre-market trading after declining over 4% on Wednesday.
  • Timber Pharmaceuticals, Inc. (NYSE:TMBR) rose 10.3% to $0.1138 in pre-market trading. Timber Pharmaceuticals recently received positive opinion on Orphan Designation from European Medicines Agency For TMB-001.
  • SmartRent, Inc. (NYSE:SMRT) rose 8.1% to $2.93 in pre-market trading after gaining around 7% on Wednesday.
  • Deutsche Bank Aktiengesellschaft (NYSE:DB) rose 6.3% to $9.14 in pre-market trading. Deutsche Bank said its New York Branch, Deutsche Bank New York, and its affiliate Deutsche Bank Trust Company Americas have raised their prime lending from 5.50% to 6.25%.

Don't forget to check out our premarket coverage here .

Losers

  • Soluna Holdings, Inc. (NASDAQ:SLNH) fell 11.9% to $1.48 in pre-market trading after gaining around 6% on Wednesday.
  • Tiziana Life Sciences Ltd (NASDAQ:TLSA) shares fell 11.6% to $0.6899 in pre-market trading after jumping 10% on Wednesday. Tiziana Life Sciences announced purchase of 20,145 common shares by Executive Chairman.
  • ECMOHO Limited (NASDAQ:MOHO) fell 9.4% to $0.1580 in pre-market trading after jumping over 50% on Wednesday.
  • China Pharma Holdings, Inc. (NYSE:CPHI) shares fell 8.6% to $0.1411 in pre-market trading.
  • Evaxion Biotech A/S (NASDAQ:EVAX) fell 8.5% to $2.13 in pre-market trading. Evaxion Biotech shares gained 14% on Wednesday after the company announced it reached an important milestone announcing today that it had enrolled its first patient in the global phase 2b clinical trial of EVX-01.
  • Brenmiller Energy Ltd (NASDAQ:BNRG) fell 7.7% to $3.56 in pre-market trading.
  • FOXO Technologies Inc. (NYSE:FOXO) fell 7.1% to $2.08 in pre-market trading after gaining over 6% on Wednesday.
  • Novavax, Inc. (NASDAQ:NVAX) fell 5.3% to $24.50 in pre-market trading. JP Morgan downgraded Novavax from Neutral to Underweight and lowered the price target from $132 to $27.
  • Ocular Therapeutix, Inc. (NASDAQ:OCUL) shares fell 4.3% to $5.56 in pre-market trading after declining 5% on Wednesday.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment